Drug Details
Nintedanib (Ofev®): Nintedanib is an anti-fibrotic drug that is approved to treat Systemic Sclerosis ILD in the United States. In clinical trials, nintedanib has been shown to slow the progression of lung function decline in this patient population.
More Information